Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study

[1]  M. Kojima,et al.  The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. , 2007, Cancer.

[2]  T. Nazeer,et al.  Role of fluorine‐18 fluoro‐deoxyglucose positron emission tomography scan in the evaluation and follow‐up of patients with low‐grade lymphomas , 2006, Cancer.

[3]  Y. Erdi,et al.  Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Hicks,et al.  Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma. , 2003, Clinical lymphoma.

[5]  Z. Keidar,et al.  Camera-based FDG PET and 67Ga SPECT in evaluation of lymphoma: comparative study. , 2003, Radiology.

[6]  R. Fisher,et al.  Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. , 2002, The American journal of medicine.

[7]  Michael E. Phelps,et al.  Effect of Whole-Body 18F-FDG PET Imaging on Clinical Staging and Management of Patients with Malignant Lymphoma , 2001 .

[8]  R. Hustinx,et al.  Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  S. Hain,et al.  2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  A. Chott,et al.  Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  S. Ben-Haim,et al.  Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. M. Mac Manus,et al.  Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  K. Maclennan,et al.  Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. , 1994, British Journal of Cancer.

[14]  J. Cox,et al.  Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  W. Velasquez,et al.  Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Gospodarowicz,et al.  Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience. , 1984, International journal of radiation oncology, biology, physics.

[17]  T. Colby,et al.  Analysis of non‐Hodgkin's lymphomas with nodular and favorable histologies, stages I and II , 1983, Cancer.

[18]  R. Schilsky,et al.  Gallium-67 scanning: limited usefulness in staging patients with non-Hodgkin's lymphoma. , 1980, The American journal of medicine.

[19]  A. Murtha,et al.  Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University. , 2001, International journal of radiation oncology, biology, physics.